Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2015-06-17 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于终止重大资产重组事项投资者说明会召开情况的公告
Investor Presentation Classification · 85% confidence The document is titled as an announcement regarding the holding of an investor explanation meeting about the termination of a major asset restructuring plan. It details the date, participants, and the Q&A session with investors about the company's merger and acquisition plans, product development, and market strategy. The document is relatively short (3570 characters) and serves as a summary of the meeting rather than a full transcript or detailed financial report. It does not contain financial statements or comprehensive financial data. It is an announcement about the investor meeting and the company's responses to investor questions, not a full call transcript or a detailed investor presentation. Therefore, the document best fits the category of an Investor Presentation (IP) as it focuses on communicating strategy, market position, and company plans to investors in a presentation-like format, despite being an announcement of the meeting held.
2015-06-17 Chinese
第二届董事会第二十一次（临时）会议（通讯方式）决议公告
Board/Management Information Classification · 95% confidence The document is titled as a resolution announcement from the company's board of directors meeting, specifically the 21st meeting of the second board. It details the nomination of a new board director candidate and adjustments to the company's stock option and restricted stock incentive plan, including changes to the number of stock options and exercise price. The document includes voting results and references to compliance with company law and articles of association. It is a formal announcement of board decisions rather than a full report or financial statement. The content aligns with announcements related to board or management information, particularly changes or nominations in the board of directors. Therefore, the document fits best under the category 'Board/Management Information (MANG)'. The document length is relatively short (2069 characters), and it is not a report publication announcement or a regulatory filing. Confidence is high due to clear references to board meeting resolutions and director nominations.
2015-06-15 Chinese
独立董事关于第二届董事会第二十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the 21st meeting of the second board of directors of the company. It references compliance with laws and regulations, discusses the nomination of a board candidate, and adjustments to stock option plans. It is a formal opinion related to board/management decisions rather than a full report or announcement of voting results. The document length is short (1158 characters) and contains detailed independent directors' opinions on board matters, which fits the category of Board/Management Information (MANG).
2015-06-15 Chinese
北京国枫律师事务所关于公司调整股票期权与限制性股票激励计划相关事项的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by Beijing Grandway Law Offices regarding adjustments to the stock option and restricted stock incentive plan of SanNuo Biological Sensing Co., Ltd. It discusses legal compliance with relevant laws and company resolutions about stock option quantities and exercise prices. The document is a standalone legal opinion related to corporate governance and stock incentive plans, not a financial report, earnings release, or shareholder meeting material. It does not contain financial statements or earnings data, nor is it a regulatory announcement or certification. Therefore, it fits best under the category of Legal Proceedings Report (LTR), as it relates to legal matters concerning corporate stock incentive adjustments.
2015-06-15 Chinese
关于股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is titled '关于股票交易异常波动的公告' which translates to 'Announcement Regarding Abnormal Stock Trading Fluctuations'. It discusses the abnormal price movements of the company's stock over two trading days, the company's investigation into the cause, and confirms no undisclosed material information or insider trading. The document is an announcement addressing stock price volatility and related disclosures, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. It is a regulatory announcement about stock trading behavior and compliance with disclosure rules. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2015-06-15 Chinese
关于调整公司股票期权与限制性股票激励计划所涉股票期权授予数量与行权价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement regarding adjustments to the company's stock option grant quantities and exercise prices under its stock option and restricted stock incentive plan. It details board meeting resolutions, independent director opinions, legal opinions, and specific adjustments to stock option quantities and prices following a capital increase and dividend distribution. The document is a formal announcement of changes related to stock-based compensation plans, not a full financial report, earnings release, or regulatory certification. It does not contain comprehensive financial statements or quarterly/yearly results. The content fits best under Capital/Financing Update (CAP) because it involves changes to the company's capital structure related to stock options and equity incentives. The document length (6105 characters) and detailed content confirm it is not a brief report publication announcement or a simple regulatory filing. Therefore, the classification is CAP with high confidence.
2015-06-15 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.